Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis

Elenir B.C. Avritscher, Scott B. Cantor, Ya Chen T. Shih, Carmelita P. Escalante, Edgardo Rivera, Linda S. Elting

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis'. Together they form a unique fingerprint.

Medicine & Life Sciences